295 related articles for article (PubMed ID: 27743484)
21. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.
Carmina E; Dewailly D; Escobar-Morreale HF; Kelestimur F; Moran C; Oberfield S; Witchel SF; Azziz R
Hum Reprod Update; 2017 Sep; 23(5):580-599. PubMed ID: 28582566
[TBL] [Abstract][Full Text] [Related]
22. Central Precocious Puberty as a Presenting Sign of Nonclassical Congenital Adrenal Hyperplasia: Clinical Characteristics.
Neeman B; Bello R; Lazar L; Phillip M; de Vries L
J Clin Endocrinol Metab; 2019 Jul; 104(7):2695-2700. PubMed ID: 30779848
[TBL] [Abstract][Full Text] [Related]
23. Clinical features suggestive of non-classical 21-hydroxylase deficiency in children presenting with precocious pubarche.
Bizzarri C; Crea F; Marini R; Benevento D; Porzio O; Ravà L; Cappa M
J Pediatr Endocrinol Metab; 2012; 25(11-12):1059-64. PubMed ID: 23329749
[TBL] [Abstract][Full Text] [Related]
24. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.
Escobar-Morreale HF; Sanchón R; San Millán JL
J Clin Endocrinol Metab; 2008 Feb; 93(2):527-33. PubMed ID: 18000084
[TBL] [Abstract][Full Text] [Related]
25. 17-Hydroxyprogesterone in children, adolescents and adults.
Honour JW
Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
[TBL] [Abstract][Full Text] [Related]
26. Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping.
Mermejo LM; Elias LL; Marui S; Moreira AC; Mendonca BB; de Castro M
J Clin Endocrinol Metab; 2005 Mar; 90(3):1287-93. PubMed ID: 15585552
[TBL] [Abstract][Full Text] [Related]
27. [Identification of congenital adrenal hyperplasia by measurement of blood-spot 17-hydroxyprogesterone].
Sólyom J; Eckhardt G; Török D
Orv Hetil; 2004 Oct; 145(40):2051-6. PubMed ID: 15559532
[TBL] [Abstract][Full Text] [Related]
28. Classical and nonclassical 21-hydroxylase deficiency: a molecular study of Argentine patients.
Dain LB; Buzzalino ND; Oneto A; Belli S; Stivel M; Pasqualini T; Minutolo C; Charreau EH; Alba LG
Clin Endocrinol (Oxf); 2002 Feb; 56(2):239-45. PubMed ID: 11874416
[TBL] [Abstract][Full Text] [Related]
29. Impaired systolic and diastolic left ventricular function in children and adolescents with congenital adrenal hyperplasia receiving corticosteroid therapy.
Tuhan H; Demircan T; Altıncık A; Çatlı G; Kızılca Ö; Egeli T; Kır M; Can Ş; Dündar B; Böber E; Abacı A
Cardiol Young; 2019 Mar; 29(3):319-324. PubMed ID: 30675832
[TBL] [Abstract][Full Text] [Related]
30. Identification of nonclassical 21-hydroxylase deficiency in girls with precocious pubarche.
Leite MV; Mendonça BB; Arnhold IJ; Estefan V; Nunes C; Nicolau W; Bloise W
J Endocrinol Invest; 1991 Jan; 14(1):11-5. PubMed ID: 1646249
[TBL] [Abstract][Full Text] [Related]
31. Adrenal steroidogenic defects in children with precocious pubarche.
del Balzo P; Borrelli P; Cambiaso P; Danielli E; Cappa M
Horm Res; 1992; 37(4-5):180-4. PubMed ID: 1337057
[TBL] [Abstract][Full Text] [Related]
32. Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization.
Sólyom J; Gács G; Keszei K; Láng K; Orley J; Petheö I; Ságodi L
Acta Endocrinol (Copenh); 1987 Jul; 115(3):413-8. PubMed ID: 3039770
[TBL] [Abstract][Full Text] [Related]
33. [Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].
Zhang Q; Wang B; Chen Y; Jiang D; Chen Y
Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):706-9. PubMed ID: 25476436
[TBL] [Abstract][Full Text] [Related]
34. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
[TBL] [Abstract][Full Text] [Related]
35. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
Hayashi GY; Carvalho DF; de Miranda MC; Faure C; Vallejos C; Brito VN; Rodrigues AS; Madureira G; Mendonca BB; Bachega TA
Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
[TBL] [Abstract][Full Text] [Related]
36. Unusual presentation with polymenorrhagia and markedly high 17-hydroxy progesterone levels in a lady with Non-Classic Congenital Adrenal Hyperplasia.
Rizwan A; Hayat M
J Pak Med Assoc; 2015 Aug; 65(8):889-91. PubMed ID: 26228339
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of late-onset congenital adrenal hyperplasia in clinical practice: current evaluation.
Sahmay S; Tuten A; Gurleyen H; Oncul M; Benian A; Tamer Erel C
Minerva Endocrinol; 2014 Sep; 39(3):215-22. PubMed ID: 25068307
[TBL] [Abstract][Full Text] [Related]
38. Genotype-Specific Cortisol Reserve in a Cohort of Subjects With Nonclassic Congenital Adrenal Hyperplasia (NCCAH).
Koren I; Weintrob N; Kebesch R; Majdoub H; Stein N; Naor S; Segev-Becker A
J Clin Endocrinol Metab; 2024 Feb; 109(3):852-857. PubMed ID: 37715965
[TBL] [Abstract][Full Text] [Related]
39. A bloodspot androstenedione assay suitable for home-monitoring of steroid replacement therapy in congenital adrenal hyperplasia.
Egan SM; Betts P; Thomson S; Wallace AM; Wood PJ
Ann Clin Biochem; 1989 May; 26 ( Pt 3)():262-7. PubMed ID: 2669617
[TBL] [Abstract][Full Text] [Related]
40. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
Santos CM; Abad LR; Cua SC; Domingo CF
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():174-8. PubMed ID: 15906729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
